DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 01 · Volume 67 · 1992 DOI: 10.1055/s-008-40043

Original Articles

001
Chafa, O; Fischer, A M; Meriane, F; Chellali, T; Sternberg, C; Otmani, F; Benabadji, M: Behçet Syndrome Associated with Protein S Deficiency
004
Boer, Karin de; Büller, Harry R; ten Cate, Jan W; Levi, Marcel: Deep Vein Thrombosis in Obstetric Patients: Diagnosis and Risk Factors
08
Lensing, Anthonie W A; Büller, Harry R; prandoni, Paolo; Batchelor, David; Molenaar, Andre H M; Cogo, Alberto; Vigo, Mario; Huisman, Peter M; ten Cate, Jan Woutert: Contrast Venography, the Gold Standard for the Diagnosis of Deep-Vein Thrombosis: lmprovement in Observer Agreement
013
Shetty, H G M; Backhouse, G; Bentley, D P; Routledge, P A: Effective Reversal of Warfarin-lnduced Excessive Anticoagulation with Low Dose Mtamin K1
016
Haan, J; Kluft, C; Leebeek, F W G; de Bart, A C W; Buruma, O J S; Roos, R A C: Hereditary Cerebral Hemorrhage with Amyloidosis -Dutch Type: A Study of Fibrinolysis
019
Addiego, Joseph E; Gomperts, Edward; Shu-Len, Liu; Bailey, Patricia; Courter, Suzanne G; Lee, Martin L; Neslund, Gerald G; Kingdon, Henry S; Griffith, Michael J: Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography
028
Hoek, J A; Nurmohamed, M T; Hamelynck, K J; Marti, R K; Knipscheer, H C; ten Cate, H; Büller, H R; Magnani, H N; ten Cate, J W: Prevention of Deep Vein Thrombosis following Total Hip Replacement by Low Molecular Weight Heparinoid
033
Béguin, Suzette; Wielders, Simone; Lormeau, J C; Hemker, H Coenraad: The Mode of Action of CY216 and CY222 in Plasma
042
Tripodi, Armando; Arbini, Arnaldo; Chantarangkul, Veena; Mannucci, Pier Mannuccio: Recombinant Tissue Factor as Substitute for Conventional Thromboplastin in the Prothrombin Time Test
046
Guglielmone, H A; Vides, M A: A Novel Functional Assay of Protein C in Human Plasma and fts Comparison with Amidolytic and Anticoagulant Assays
050
Kazama, Yoshiaki; Koide, Takehiko: Modulation of Protein C Inhibitor Activity by Histidine-Rich Glycoprotein and Platelet Factor 4: Role of Zinc and Calcium Ions in the Heparin-Neutralizing Ability of Histidine-Rich Glycoprotein
056
Knabb, Robert M; Kettner, Charles A; Timmermans, Pieter B M W M; Reilly, Thomas M: In Vivo Characterization of a New Synthetic Thrombin Inhibitor
060
Harsfalvi, J; Tarcsa, E; Udvardy, M; Zajka, G; Szarvas, T; Fesus, L: Presence and Possible Origin of ɛ(γ-Glutamyl)Lysine Isodipeptide in Human Plasma
063
Taylor, Sherryl A M; Duffin, Jacalyn; Cameron, Cherie; Teitel, Jerome; Garvey, Bernadette; Lillicrap, David P: Characterization of the Original Christmas Disease Mutation (Cysteine 206 → Serine): From Clinical Recognition to Molecular Pathogenesis
066
Green, Peter M; Montandon, A Jane; Ljung, Rolf; Nilsson, lnga Marie; Giannelli, Francesco: Haplotype Analysis of Identical Factor IX Mutants Using PCR
070
Blombäck, M; Eneroth, P; Landgren, B-M; Lagerström, M; Anderson, O: On the Intraindividual and Gender Variability of Haemostatic Components
076
Juhan-Vague, I; Alessi, M C; Raccah, D; Aillaud, M F; Billerey, M; Ansaldi, J; Philip-Joet, C; Vague, P: Daytime Fluctuations of Plasminogen Activator Inhibitor 1 (PAI-1) in Populations with High PAI-1 Levels
083
de Boer, A; Kluft, C; Kroon, J M; Kasper, F J; Schoemaker, H C; Pruis, J; Breimer, D D; Soons, P A; Emeis, Jef J; Cohen, Adam F: Liver Blood Flow as a Major Determinant of the Clearance of Recombinant Human Tissue-Type Plasminogen Activator
088
Zacharias, Ute; Fischer, Bernhard; Noll, Franz; Will, Horst: Characterization of Human Tissue-Type Plasminogen Activator with Monoclonal Antibodies: Mapping of Epitopes and Binding Sites for Fibrin and Lysine
095
Declerck, Paul J; Van Keer, Leen; Verstreken, Maria; Collen, Désiré: An Enzyme-Linked Immunosorbent Assay for Urokinase-Type Plasminogen Activator (u-PA) and Mutants and Chimeras Containing the Serine Protease Domain of u-PA
101
Loon, B J Potter van; Rijken, D C; Brommer, E J P; van der Maas, A P C: The Amount of Plasminogen, Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1 in Human Thrombi and the Relation to IVVO-TNO Lysibility
106
Carr, Marcus E; Krishnamurti, C; Alving, B M: Effect of Plasminogen Activator Inhibitor-1 on Tissue-Type Plasminogen Activator-Induced Fibrinolysis
111
Levi, Marcel; Boer, Jan Paul de; Roem, Dorina; Cate, Jan Wouter ten; Hack, C Erik: Plasminogen Activation In Vivo upon Intravenous Infusion of DDAVP
117
Vuorinen-Markkola, Helena; Puhakainen, llpo; Yki-Järvinen, Hannele: No Evidence for Short-Term Regulation of Plasminogen Activator Inhibitor Activity by Insulin in Man
121
Morgenstern, Eberhard; Ruf, Andreas; Patscheke, Heinrich: Transport of Anti-Glycoprotein IIb/IIIa-Antibodies into the Alpha-Granules of Unstimulated Human Blood Platelets
126
Spertini, Olivier; Hauert, Jacques; Bachmann, Fedor: Reaction of Acetaldehyde with Human Platelets
131
Rybak, Mary Ellen M; Renzulli, Lori A: Effect of Calcium Channel Blockers on Platelet GPIIb-IIIa as a Calcium Channel in Liposomes: Comparison with Effects on the Intact Platelet
137
Saggin, Leopoldo; Cazzola, Flavia; Corona, Giuseppe; Salvatico, Emanuela; Cella, Giuseppe; Prosdocimi, Marco: Neutralization of the Antiheparin Activity of Platelet Factor 4 by a Monoclonal Antibody
144
Ushikubi, Fumitaka; lshibashi, Takafumi; Narumiya, Shu; Okuma, Minoru: Analysis of the Defective Signal Transduction Mechanism through the Platelet Thromboxane A2 Receptor in a Patient with Polycythemia Vera
147
George, F; Brisson, C; Poncelet, P; Laurent, J C; Massot, O; Arnoux, D; Ambrosi, P; Klein-Soyer, C; Cazenave, J P; Sampol, J: Rapid Isolation of Human Endothelial Cells from Whole Blood Using S-Endo1 Monoclonal Antibody Coupled to Immuno-Magnetic Beads: Demonstration of Endothelial Injury after Angioplasty
154
Meulien, P; Nishino, M; Mazurier, C; Dott, K; Piétu, G; Jorieux, S; Pavirani, A; Girma, J P; Oufkir, D; Courtney, M; Meyer, D: Processing and Characterization of Recombinant von Willebrand Factor Expressed in Different Cell Types Using a Vaccinia Virus Vector
161
Silveira, Angela M V; Elgue, Graciela; Hamsten, Anders; Blombäck, Margareta: von Willebrand Factor in Plasma and Urine of Men with Premature Coronary Artery Disease
166
Ginsburg, David; Bockenstedt, Paula L; Allen, Elizabeth A; Fox, David A; Foster, Paul A; Ruggeri, Zaverio M; Zimmerman, Theodore S; Montgomery, Robert R; Bahou, Wadie F; Johnson, Timothy A; Yang, Angela Y: Fine Mapping of Monoclonal Antibody Epitopes on Human von Willebrand Factor Using a Recombinant Peptide Library
172
Royston, B D; Royston, D; Coade, S B; Morgan, D M L; Pearson, J D: Aprotinin Does Not Inhibit the Release of PGI2 or vWF from Cultured Human Endothelial Cells
176
Millet, Jean; Theveniaux, Jocelyne; Brown, Neil L: The Venous Antithrombotic Effect of LF 1351 in the Rat following Oral Administration

Letters to the Editor

180
Forestier, F; Solé, Y; Aiach, M; Gélas, M Alhenc; Daffos, F: Absence of Transplacental Passage of Fragmin (Kabi) during the Second and the Third Trimesters of Pregnancy
182
Saitoh, Masahiro; Slayter, Henry S; Watkins, Simon C; Ware, J Anthony: Cytoplasmic Localization of Aequorin Loaded into Human Platelets by a New Method
183
Castaman, Giancarlo; Rodeghiero, Francesco; Lattuada, Antonella; Mannucci, Pier Mannuccio; Bonomi, A Bianchi: Subunit Composition of Plasma von Willebrand Factor (vWF) in Two Uremic Patients with Acquired vWF Abnormalities
184
Kreuz, W; Auerswald, G; Brückmann, C; Zieger, B; Linde, R; Funk, M; Auberger, K; Sutor, A H; Rasshofer, R; Roggendorf, M: Prevention of Hepatitis C Virus Infestion in Children with Haemophilia A and B and von Willebrand’s Disease
185
Lethagen, Stefan; Rugarn, Peter: The Effect of DDAVP and Placebo on Platelet Function and Prolonged Bleeding Time Induced by Oral Acetyl Salicylic Acid Intake in Healthy Volunteers